These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

742 related items for PubMed ID: 1988628

  • 1. Therapeutic radionuclides: production and decay property considerations.
    Volkert WA, Goeckeler WF, Ehrhardt GJ, Ketring AR.
    J Nucl Med; 1991 Jan; 32(1):174-85. PubMed ID: 1988628
    [Abstract] [Full Text] [Related]

  • 2. Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters.
    Govindan SV, Goldenberg DM, Elsamra SE, Griffiths GL, Ong GL, Brechbiel MW, Burton J, Sgouros G, Mattes MJ.
    J Nucl Med; 2000 Dec; 41(12):2089-97. PubMed ID: 11138697
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cellular dose conversion factors for alpha-particle--emitting radionuclides of interest in radionuclide therapy.
    Hamacher KA, Den RB, Den EI, Sgouros G.
    J Nucl Med; 2001 Aug; 42(8):1216-21. PubMed ID: 11483682
    [Abstract] [Full Text] [Related]

  • 5. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W.
    Cancer Res; 1999 Jun 01; 59(11):2635-43. PubMed ID: 10363986
    [Abstract] [Full Text] [Related]

  • 6. [Use of radionuclides in therapy].
    Vucina J, Han R.
    Med Pregl; 2001 Jun 01; 54(5-6):245-50. PubMed ID: 11759220
    [Abstract] [Full Text] [Related]

  • 7. Options to meet the future global demand of radionuclides for radionuclide therapy.
    Das T, Pillai MR.
    Nucl Med Biol; 2013 Jan 01; 40(1):23-32. PubMed ID: 23116551
    [Abstract] [Full Text] [Related]

  • 8. Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesin.
    Moustapha ME, Ehrhardt GJ, Smith CJ, Szajek LP, Eckelman WC, Jurisson SS.
    Nucl Med Biol; 2006 Jan 01; 33(1):81-9. PubMed ID: 16459262
    [Abstract] [Full Text] [Related]

  • 9. Steps towards cancer therapy with radionuclides--a review including radiation biophysical aspects.
    Kampf G.
    Radiobiol Radiother (Berl); 1990 Jan 01; 31(3):215-29. PubMed ID: 2201055
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Trifunctional somatostatin-based derivatives designed for targeted radiotherapy using auger electron emitters.
    Ginj M, Hinni K, Tschumi S, Schulz S, Maecke HR.
    J Nucl Med; 2005 Dec 01; 46(12):2097-103. PubMed ID: 16330576
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recoil effect on beta-decaying in vivo generators, interpreted for (103)Pd/(103m)Rh.
    Szucs Z, van Rooyen J, Zeevaart JR.
    Appl Radiat Isot; 2009 Dec 01; 67(7-8):1401-4. PubMed ID: 19297176
    [Abstract] [Full Text] [Related]

  • 15. Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
    Behr TM, Sgouros G, Stabin MG, Béhé M, Angerstein C, Blumenthal RD, Apostolidis C, Molinet R, Sharkey RM, Koch L, Goldenberg DM, Becker W.
    Clin Cancer Res; 1999 Oct 01; 5(10 Suppl):3031s-3043s. PubMed ID: 10541340
    [Abstract] [Full Text] [Related]

  • 16. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS, Dhagat NN.
    Indian J Environ Health; 2001 Apr 01; 43(2):1-82. PubMed ID: 12397675
    [Abstract] [Full Text] [Related]

  • 17. Bremsstrahlung radiation exposure from pure beta-ray emitters.
    Zanzonico PB, Binkert BL, Goldsmith SJ.
    J Nucl Med; 1999 Jun 01; 40(6):1024-8. PubMed ID: 10452321
    [Abstract] [Full Text] [Related]

  • 18. Gene therapy using antisense oligodeoxynucleotides labeled with Auger-emitting radionuclides.
    Kairemo KJ, Tenhunen M, Jekunen AP.
    Cancer Gene Ther; 1998 Jun 01; 5(6):408-12. PubMed ID: 9917096
    [Abstract] [Full Text] [Related]

  • 19. 177Lu-antibody conjugates for single-cell kill of B-lymphoma cells in vitro and for therapy of micrometastases in vivo.
    Michel RB, Andrews PM, Rosario AV, Goldenberg DM, Mattes MJ.
    Nucl Med Biol; 2005 Apr 01; 32(3):269-78. PubMed ID: 15820762
    [Abstract] [Full Text] [Related]

  • 20. The promise of targeted {alpha}-particle therapy.
    Mulford DA, Scheinberg DA, Jurcic JG.
    J Nucl Med; 2005 Jan 01; 46 Suppl 1():199S-204S. PubMed ID: 15653670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.